Qamzova (Meloxicam)

Generic Name

Meloxicam

Brand Names

Qamzova, Symbravo, Xifyrm, Zybic

FDA approval date: November 01, 2005

Classification: Nonsteroidal Anti-inflammatory Drug

Form: Injection, Tablet, Suspension, Capsule

What is Qamzova (Meloxicam)?

QAMZOVA is indicated for use in adults for the management of moderate-to-severe pain, alone or in combination with non-NSAID analgesics. Limitation of Use Because of delayed onset of analgesia, QAMZOVA alone is not recommended for use when rapid onset of analgesia is required. QAMZOVA contains meloxicam, which is an NSAID, and is indicated for use in adults for the management of moderate-to-severe pain, alone or in combination with non-NSAID analgesics. Limitation of Use Because of delayed onset of analgesia, QAMZOVA alone is not recommended for use when rapid onset of analgesia is required.

Approved To Treat

Top Global Experts

Save this treatment for later

Not sure about your diagnosis?

Check Your Symptoms

Related Clinical Trials

The Effect of Multimodal Pain Regimen on Use of Narcotics After Rotator Cuff Tear Repair

Enrollment Status: Recruiting

Publish Date: July 13, 2026

Intervention Type: Drug

Study Phase: Phase 4

Summary: The goal of this clinical trial is to understand which group of pain control medications work best in adults after rotator cuff surgery.

Zynrelef vs Exparel: The Battle of Postoperative Pain Control After Robotic Sleeve Gastrectomy

Enrollment Status: Recruiting

Publish Date: July 08, 2026

Intervention Type: Drug

Study Phase: Early Phase 1

Summary: The purpose of this study is to evaluate the use of an injectable combination of bupivacaine and meloxicam (Zynrelef) vs injectable liposomal bupivacaine (Exparel), two extended local anesthesia strategies currently approved by FDA and on the market for post-surgical pain control. The investigators plan on randomizing study participants to either Exparel or Zynrelef at the closure site of robotic ...

Comparative Efficacy of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) With Distinct Chemical Structures in Shoulder Adhesive Capsulitis and the Role of Pain Phenotypes

Enrollment Status: Recruiting

Publish Date: May 14, 2026

Intervention Type: Drug

Study Phase: Not Applicable

Summary: Patients aged 18-75 years who present to a tertiary rehabilitation hospital with shoulder pain and restricted range of motion, and who consent to participate, will be included in the study. Eligibility will be determined based on predefined inclusion and exclusion criteria. Eligible patients will be randomly assigned to receive one of several nonsteroidal anti-inflammatory drugs (NSAIDs) with diff...

View All Clinical Trials